Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced inflammation on a similar level to statins, cutting chances of a repeat attack. Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced inflammation on a similar level to statins, cutting chances of a repeat attack.
Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests
